•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.3 Dividend Titans With Pricing Power Straight From The Hedge Fund Playbook
Danaher Q3 Preview: Market Share Gains In Molecular Testing
Automated and Closed Cell Therapy Market Research 2024-2029 Featuring Leading Players - Danaher, Thermo Fischer Scientific, Lonza, and Sartorius
The Ultimate 5: My Highest-Conviction Dividend Stocks
Danaher Schedules Third Quarter 2024 Earnings Conference Call
The Big 3: ANET, MET, DHR
Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Danaher Announces Quarterly Dividend
Here's Why It is Appropriate to Retain Danaher Stock For Now
Danaher Confirms Third Quarter and Full Year 2024 Guidance
HTHIY or DHR: Which Is the Better Value Stock Right Now?
Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.
Danaher: Lofty Price, Bright Future
Why Is Danaher (DHR) Up 2% Since Last Earnings Report?
Danaher (DHR) Benefits From Business Strength Amid Risks
Betting Big: 3 Dividend Stocks My Family And I Are Buying Aggressively
HTHIY or DHR: Which Is the Better Value Stock Right Now?
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y
Danaher Stock Soars on Q2 Earnings Beat
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.